EW - Edwards Lifesciences Corporation

NYSE - Nasdaq Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
4,151,600
3,722,800
3,435,300
2,963,700
2,493,700
Cost of Revenue
1,062,900
939,400
875,300
797,400
617,200
Gross Profit
3,088,700
2,783,400
2,560,000
2,166,300
1,876,500
Operating Expenses
Research Development
721,900
622,200
552,600
477,800
383,100
Selling General and Administrative
1,183,100
1,088,500
984,700
904,700
850,700
Total Operating Expenses
1,905,000
1,710,700
1,537,300
1,382,500
1,233,800
Operating Income or Loss
1,183,700
1,072,700
1,022,700
783,800
642,700
Interest Expense
-
29,900
23,200
19,200
17,200
Total Other Income/Expenses Net
-343,500
-313,400
15,100
-37,500
-11,000
Income Before Tax
849,200
761,400
1,034,900
737,900
622,400
Income Tax Expense
75,500
39,200
451,300
168,400
127,500
Income from Continuing Operations
773,700
722,200
583,600
569,500
494,900
Net Income
773,700
722,200
583,600
569,500
494,900
Net Income available to common shareholders
773,700
722,200
583,600
569,500
494,900
Reported EPS
Basic
-
3.45
2.95
2.67
2.30
Diluted
-
3.38
2.88
2.61
2.25
Weighted average shares outstanding
Basic
-
209,200
210,900
213,000
215,500
Diluted
-
213,600
215,900
217,800
220,300
EBITDA
-
868,700
1,140,000
828,300
642,700